WO2019161634A1 - Preparation method for rebaudioside a, enzyme for rebaudioside a preparation, and application - Google Patents

Preparation method for rebaudioside a, enzyme for rebaudioside a preparation, and application Download PDF

Info

Publication number
WO2019161634A1
WO2019161634A1 PCT/CN2018/096211 CN2018096211W WO2019161634A1 WO 2019161634 A1 WO2019161634 A1 WO 2019161634A1 CN 2018096211 W CN2018096211 W CN 2018096211W WO 2019161634 A1 WO2019161634 A1 WO 2019161634A1
Authority
WO
WIPO (PCT)
Prior art keywords
glucosyltransferase
rebaudioside
stevioside
reaction
raw material
Prior art date
Application number
PCT/CN2018/096211
Other languages
French (fr)
Chinese (zh)
Inventor
傅荣昭
李振伟
刘文山
刘玉凤
Original Assignee
邦泰生物工程(深圳)有限公司
江西邦泰绿色生物合成生态产业园发展有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 邦泰生物工程(深圳)有限公司, 江西邦泰绿色生物合成生态产业园发展有限公司 filed Critical 邦泰生物工程(深圳)有限公司
Priority to PCT/CN2018/096211 priority Critical patent/WO2019161634A1/en
Priority to CN201880001964.4A priority patent/CN109196110A/en
Publication of WO2019161634A1 publication Critical patent/WO2019161634A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/56Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

Definitions

  • the invention relates to the field of biomedical technology, in particular to a preparation method of rebaudioside A, an enzyme for preparing lysine A and application thereof.
  • Steviol glycoside also known as stevioside, is a low-calorie, high-intensity sweetener with a sweetness 150-300 times that of sucrose and about 1/300 of that of sucrose. Studies have shown that it has no toxic side effects, is safe to eat, and studies have shown that stevioside can be used to prevent high blood pressure, diabetes, obesity, heart disease and dental caries, and is an ideal sweetener for replacing sucrose.
  • Stevioside Stevioside
  • RA Lai Di Di A
  • the present invention provides a preparation method of Lai Di Di A, an enzyme for preparing Lai Di Di A and an application thereof; the preparation method has the advantages of simple process, high yield, low cost and green safety.
  • the present invention provides a method of preparing lysine A, comprising:
  • the reaction solution is prepared by using the stevioside raw material as a substrate, and the pH of the reaction solution is adjusted to 6.0-8.0 at a constant temperature of 20-45. After the stirring reaction is carried out at ° C, the rebaudioside A is collected; the stevioside raw material includes stevioside, and the amino acid sequence of the glucosyltransferase includes the amino acid sequence shown in SEQ ID NO: 1.
  • the glucosyltransferase of the present invention is derived from Gardenia jasminoides.
  • the uridine diphosphate glucose (UDPG) may also be referred to as uridine-5'-diphosphate glucose or uridine diphosphate glucose.
  • the stevioside (St), or stevioside has a molecular formula of C 38 H 60 O 18 and has a chemical structure as shown in Formula I.
  • the Lydia A (RA), or stevioside A, A-side stevioside has the formula C 44 H 70 O 23 , and the chemical structure is as shown in Formula II:
  • the stevioside raw material comprises stevioside (St), and the stevioside and the uridine diphosphate glucose are catalyzed by a glucosyltransferase to obtain rebaudioside A (RA), and the diphosphate Uridine glucose forms Uridine triphosphate (UDP) in the reaction.
  • the uridine diphosphate may also be referred to as uridine-5'-diphosphate.
  • the uridine diphosphate glucose in the reaction liquid is obtained by directly adding in the reaction liquid or by adding a mixed raw material to the reaction liquid, the mixed raw material including uridine diphosphate (UDP) And one or both of the uridine diphosphate glucose, Sucrose and Sucrose Synthase (SuS).
  • the mixed raw material includes uridine diphosphate, uridine diphosphate glucose, sucrose, and sucrose synthase, or the mixed raw material includes uridine diphosphate glucose, sucrose, and sucrose synthase, or the mixed raw material includes uridine Diphosphate, sucrose and sucrose synthase.
  • the sucrose synthase (SuS) also known as sucrose synthase, is a glycosyltransferase widely present in plants.
  • the process route of the preparation method of the rebaudioside A may also be as shown in the formula (2):
  • the uridine diphosphate, the sucrose and the sucrose synthase are reacted in the reaction solution to obtain the uridine diphosphate glucose and form the uridine diphosphate glucose regeneration system;
  • the stevioside is prepared by the catalysis of the glucosyltransferase, and the glucosyltransferase is capable of reintroducing a glucosyl group on the sugar group of the carbon atom at the 13 position of the stevioside
  • the sucrose produces fructose catalyzed by the sucrose synthase.
  • the gene coding sequence of the glucosyltransferase comprises the nucleotide sequence set forth in SEQ ID NO: 2.
  • the gene coding sequence of the amino acid sequence of the glucosyltransferase should consider a degenerate base, ie, the coding gene of the amino acid sequence shown in SEQ ID NO: 1 includes the nucleus as shown in SEQ ID NO: The nucleotide sequence, the protective range should also protect the nucleotide sequence having the base degenerate property of SEQ ID NO: 2, and the amino acid sequence corresponding to these nucleotide sequences is still SEQ ID NO: 1.
  • the mass ratio of the uridine diphosphate, the sucrose and the sucrose synthase is (0.0001-0.04): (0.1 -2): (0.1-1). Further, optionally, the mass ratio of the uridine diphosphate, the sucrose and the sucrose synthase is (0.005-0.01): 1: (0.2-1).
  • the mass ratio of the uridine diphosphate glucose to the stevioside is (0.001-1) :1. Further, optionally, the mass ratio of the uridine diphosphate glucose to the stevioside is (0.01-0.3):1.
  • the mixed raw material includes the uridine diphosphate glucose, sucrose, and sucrose synthase
  • the uridine diphosphate glucose is catalyzed by the glucosyltransferase to obtain urine in the reaction solution.
  • the glycoside diphosphate, the sucrose, the sucrose synthase, and the uridine diphosphate can be reacted to form uridine diphosphate glucose, and a cyclic regeneration system of the uridine diphosphate glucose is formed in the reaction solution.
  • the sucrose synthase is derived from one or more of Arabidopsis thaliana, soybeans, and potatoes. Further, optionally, the sucrose synthase is derived from Arabidopsis thaliana.
  • the stevioside raw material has a mass fraction of 10%-30% in the reaction solution. Further, optionally, the mass fraction of the stevioside raw material in the reaction liquid is 20% to 30%. For example, the stevioside raw material has a mass fraction of 10%, or 18%, or 25%, or 30% in the reaction liquid.
  • the mass ratio of the stevioside raw material to the glucosyltransferase is 1: (0.1-1);
  • the added form of the glucosyltransferase comprises a crude enzyme solution or an enzyme powder.
  • the crude enzyme solution of the glucosyltransferase refers to a microorganism disruption buffer containing a glucosyltransferase, and the microorganism can synthesize the glucosyltransferase.
  • the enzyme powder of the glucosyltransferase refers to a freeze-dried enzyme powder obtained by purifying the glucosyltransferase.
  • the reaction temperature of the reaction liquid is maintained at 20 to 45 °C. Further, optionally, the reaction temperature of the reaction liquid is maintained at 35 to 40 °C. For example, the reaction temperature of the reaction liquid is maintained at 20 ° C, or 30 ° C, or 35 ° C, or 38 ° C, or 40 ° C.
  • the glucosyltransferase has a high catalytic activity at the temperature range, and the conversion rate of the stevioside is high.
  • the pH of the reaction solution is adjusted to be 7.0 to 8.0.
  • the pH of the reaction solution is adjusted to 7.2, or 7.4, or 8.0.
  • the reaction time of the stirring reaction is 4-25 hours.
  • the stirring reaction is stirred at a rate of 200-300 rpm.
  • the reaction time of the stirring reaction is 10-20 hours.
  • the reaction time of the stirring reaction is 4 hours, or 10 hours, or 15 hours, or 20 hours.
  • the process of collecting the rebaudioside A comprises: heating the reaction solution to denature the glucosyltransferase, filtering and collecting the filtrate, and purifying the filtrate to obtain Lai Didi A, wherein the heating temperature is 85-100 ° C and the time is 0.3-1 hour.
  • the rebaudioside A may have partial loss during the purification treatment, and the sweetness, heat and physical and chemical properties of the rebaudioside A obtained after the purification treatment are in accordance with actual theoretical parameters.
  • the mass ratio of the stevioside to the sucrose is 1: (0.2-1).
  • the reaction solution further includes a buffer
  • the buffer includes one or more of a phosphate buffer solution, a borate buffer solution, and a Tris-HCl buffer solution.
  • the concentration of the buffer is 10-500 mmol/L.
  • the concentration of the buffer is 100-500 mmol/L.
  • the concentration of the buffer is 100 mmol/L, or 200 mmol/L, or 500 mmol/L.
  • the buffer also includes other types of buffers.
  • the preparation method of the rebaudioside A provided by the first aspect of the invention has the advantages of simple process, low cost and green environmental protection; and the rebaudioside A has an extremely high yield.
  • the conversion rate of the preparation method of the present invention is as high as 90% or even 99%.
  • the preparation method of Lai Di Di A can only use a substrate concentration of a few thousandths, and the conversion rate is low; even if the raw material is added by a method such as adding raw materials, the conversion rate is still limited, and therefore, the prior art as a whole
  • the high cost is not conducive to industrial production.
  • the preparation method of the invention does not use a large amount of organic reagents, and the concentration of the substrate of the invention can be as high as 10-30%, and can be used to recycle the diphosphate urine with high raw material cost through the uridine diphosphate glucose regeneration system.
  • Glycoside Glucose (UDPG) Glycoside Glucose (UDPG); Therefore, the preparation method of the invention has low cost, is environmentally friendly, has few purification steps, and has great application prospects.
  • the present invention provides an enzyme for preparing rebaudioside A, wherein the enzyme for preparation is a glucosyltransferase, and the gene coding sequence of the glucosyltransferase comprises SEQ ID NO: 2 The nucleotide sequence shown.
  • the amino acid sequence of the glucosyltransferase comprises the amino acid sequence set forth in SEQ ID NO: 1.
  • the glucosyltransferase is produced by microbial expression, including one or more of Escherichia coli, Pichia pastoris, and Bacillus subtilis. Further, optionally, the glucosyltransferase is produced by expression in E. coli. The glucosyltransferase is heterologously expressed in the system in which the E. coli expression is expressed.
  • the present invention preferably has an E. coli expression system which is simple and feasible, has a short culture period, low fermentation cost, and high enzyme yield.
  • the glucosyltransferase of the present invention may be added to the reaction solution in the form of an enzyme powder or a crude enzyme solution.
  • the glucosyltransferase of the present invention is derived from gardenia, and the gene coding sequence of the glucosyltransferase is screened by a large number of experiments and purified by optimizing the microbial expression system.
  • the enzymatic properties of glucosyltransferases from different species are different, including the specific activity of the enzyme, the substrate range of the enzyme, the optimum pH, the optimum temperature, the action time and the stability of the enzyme.
  • the present invention finds that another glucosyltransferase derived from gardenia does not have the catalytic conversion of stevioside to Laiwudi. ⁇ A's function.
  • the glucosyltransferase of the present invention has extremely strong specificity, and the rebaudioside A can be efficiently catalyzed by the stevioside.
  • the stevioside raw material may further be a mixture comprising stevioside as a main component, and the glucosyltransferase of the present invention can efficiently and specifically catalyze the conversion of the stevioside to rebaudioside A.
  • the glucosyltransferase is expressed in a microorganism by constructing a recombinant plasmid whose vector plasmid is a pET28a(+) vector plasmid. Inserting the gene coding sequence of the glucosyltransferase into the pET28a(+) vector plasmid to obtain a recombinant plasmid capable of efficiently and efficiently producing heterologous expression in a microbial cell to obtain the glucosyltransferase .
  • the nucleotide sequence of the His-tag (histidine tag) is added to the gene coding sequence of the glucosyltransferase, and the expressed protein is tagged with His tag, and the His tag is favorable for separation of the expressed protein. Purification, and analysis and tracing in experiments, such as for analysis in immunoblot experiments.
  • the gene coding sequence for the glucosyltransferase is inserted between the BamH I and Hind III restriction sites of the pET28a(+) vector plasmid.
  • the gene coding sequence of the glucosyltransferase is inserted into the pET28a(+) vector plasmid, the 5' end of the gene coding sequence of the glucosyltransferase may be added with a start codon (such as ATG) and a pET28a (+) vector.
  • the BamHI restriction site is ligated in the plasmid, and the stop codon (such as TAA) can be added to the 3' end to be ligated with the Hind III restriction site in the pET28a(+) vector plasmid.
  • the stop codon such as TAA
  • the present invention also provides a biocatalytic use of a glucosyltransferase and a microorganism strain comprising the gene of the glucosyltransferase, the amino acid sequence of the glucosyltransferase comprising SEQ ID NO: The amino acid sequence shown; the glucosyltransferase catalyzes the conversion of stevioside to rebaudioside A.
  • the glucosyltransferase is encoded by a glucosyltransferase gene derived from gardenia, and the gene coding sequence of the glucosyltransferase comprises the nucleotide sequence set forth in SEQ ID NO: 2.
  • the preparation method of the rebaudioside A according to the invention is a biological enzymatic method, the preparation method is simple and efficient, low in cost, high in conversion rate and green in safety, and can be widely applied to industrial scale production;
  • the final concentration of the substrate is far greater than the prior art, and the final concentration of the substrate can reach 10%-30%;
  • the Laiwudi A obtained by the preparation method of the invention has high purity and high yield and can be widely applied in the food industry and the pharmaceutical field;
  • the preparation method of the preparation method of the rebaudioside A of the present invention is characterized in that the enzyme-glucosyltransferase is highly specific and can efficiently convert the stevioside to the rebaudioside A.
  • FIG. 1 is a plasmid map of a recombinant plasmid pET28a-RA07 according to an embodiment of the present invention.
  • the gene coding sequence of the glucosyltransferase (RA07) comprises a nucleotide sequence as shown in SEQ ID NO: 2,
  • the amino acid sequence of the glucosyltransferase comprises the amino acid sequence set forth in SEQ ID NO: 1; the glucosyltransferase is derived from gardenia.
  • FIG. 1 is a representation of the recombinant plasmid pET28a-RA07.
  • the constructed recombinant plasmid pET28a-RA07 was transferred into E. coli BL21 (DE3), and inoculated into 4 mL of LB medium at a 1% inoculation amount, maintaining a constant 37 ° C, shaking rate of 200 rpm, after overnight culture. Transfer the bacterial solution to a 2L flask containing 1L of LB medium (50 ⁇ g/mL kanamycin) at 1% inoculation, and continue to incubate at 37 °C until the OD600 value in the medium reaches 0.6 or so.
  • the obtained crude enzyme solution containing RA07 was identified by SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
  • SDS-PAGE SDS-polyacrylamide gel electrophoresis
  • the molecular size of the RA07 is in agreement with a theoretically calculated value, and the theoretical molecular weight of the RA07 is 53 KD.
  • the collected enzyme solution is freeze-dried to further prepare an enzyme powder of RA07.
  • glucosyltransferases RA01-RA11 derived from different species obtained by experiments; wherein, the specific source of each of the glucosyltransferases is shown in the following table; wherein RA01 is derived from Stevia rebaudiana, RA02 From sunflower (Helianthus annuus), RA03 from rice (Oryza sativa), RA04 from Brachypodium distachyon, RA05 from Stevia rebaudiana, RA06 from Rauvolfia serpentina RA07 is derived from Gardenia jasminoides, RA08 is derived from Catharanthus roseus, RA09 is derived from Gardenia jasminoides, RA10 is derived from Picrorhiza kurrooa, and RA11 is derived from Lactobacillus. Reuteri 180), RA12 is derived from barley (Hordeum vulgare subsp. Vulgare);
  • RA02-RA06 and RA08-RA12 had no enzymatic activity and could not catalyze the conversion of stevioside to Laiwudi A, RA01.
  • the enzyme activity is low, the catalytic effect is poor, and RA07 has extremely high enzymatic activity, strong catalytic performance, and the conversion rate is as high as 99%, and the stevioside can be efficiently catalyzed to obtain the rebaudioside A;
  • the enzymatic properties of the enzymes of the same species are also greatly different.
  • both RA01 and RA05 are derived from stevia, and both RA07 and RA09 are derived from gardenia, but the catalytic properties of the two are greatly different.
  • the conversion rate is calculated by measuring the stevioside content in the reaction liquid by liquid chromatography after completion of the stirring reaction.
  • a method for preparing Lai Di Di A comprising:
  • the product was denatured and filtered to remove the protein, and the filtrate was collected and spray-dried to obtain a crude product of rebaudioside A.
  • the crude product of Lycopidiside A was separated by silica gel resin, crystallized, etc., and purified by post-treatment to obtain a lyophilized A 96.22 g. >95%.
  • a method for preparing Lai Di Di A comprising:
  • a method for preparing Lai Di Di A comprising:
  • a method for preparing Lai Di Di A comprising:
  • the protein of RA07 was denatured and filtered to remove the protein.
  • the filtrate was collected and spray-dried to obtain a crude product of rebaudioside A.
  • the crude product of rebaudioside A was separated by silica gel resin, crystallized, etc., and then purified to obtain a lyophilized A 94.37 g. , purity >95%.
  • a method for preparing Lai Di Di A comprising:
  • the protein of RA07 was denatured and filtered to remove the protein.
  • the filtrate was collected and spray-dried to obtain a crude product of rebaudioside A.
  • the crude product of rebaudioside A was separated by silica gel resin, crystallized, etc., and purified by post-treatment to obtain Lai Di Di A 95.01 g. , purity >95%.
  • a method for preparing Lai Di Di A comprising:
  • boric acid buffer 200 g of stevioside, 120 g of sucrose and 1.5 g of UDP were added, respectively, and stirred until completely dissolved; glucosyltransferase RA07 enzyme powder 80 g and sucrose synthase (from Arabidopsis thaliana, NP_197583) 60 g were continuously added.
  • the total volume of the reaction system is 1 L, and the pH of the system is adjusted to 7.4; the reaction is carried out at a constant temperature of 37 ° C and a stirring rate of 250 rpm for 20 hours, and the conversion rate is 98% by the experiment. After the reaction is completed, the reaction liquid is heated to 100 ° C for 0.5 h.
  • the protein of RA07 was denatured and the protein was removed by filtration, and the filtrate was collected and spray-dried to obtain a crude product of rebaudioside A.
  • the crude product of rebaudioside A was separated by silica gel resin, crystallized, etc., and then purified to obtain a lycopene A 190.02. g, purity > 95%.
  • a method for preparing Lai Di Di A comprising:
  • the boric acid buffer solution 300 g of stevioside, 150 g of sucrose and 2 g of UDP were added, respectively, and stirred until completely dissolved; 100 g of glucosyltransferase RA07 enzyme powder and 80 g of sucrose synthase (derived from Arabidopsis thaliana, NP_197583) were continuously added.
  • the total volume of the reaction system was 1 L, and the pH of the system was adjusted to 7.4.
  • the reaction was carried out for 20 h at a constant temperature of 37 ° C and a stirring rate of 300 rpm. The conversion was 96% by the experiment. After the reaction was completed, the reaction solution was heated to 100 ° C for 0.5 h.
  • the protein of RA07 was denatured and filtered to remove the protein.
  • the filtrate was collected and spray-dried to obtain a crude product of rebaudioside A.
  • the crude product of rebaudioside A was separated by silica gel resin, crystallized, etc., and then purified to obtain a lycopene A 290.25g. , purity >95%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Provided is a preparation method for rebaudioside A, said method comprising: in the presence of uridine diphosphate glucose and a glycosyltransferase, using a steviol glycoside raw material as a substrate to prepare a reaction solution, and stirring and reacting at a constant temperature of 20-45°C to obtain rebaudioside A. The steviol glycoside raw material comprises stevioside, and the glycosyltransferase comprises the amino acid sequence shown in SEQ ID NO: 1. Also provided are an enzyme for rebaudioside A preparation, and an application.

Description

莱苞迪甙A的制备方法、莱苞迪甙A制备用酶及应用Preparation method of Lai Di Di A, enzyme for preparation of Lai Di Di A and application thereof 技术领域Technical field
本发明涉及生物医药技术领域,特别涉及莱苞迪甙A的制备方法、莱苞迪甙A制备用酶及应用。The invention relates to the field of biomedical technology, in particular to a preparation method of rebaudioside A, an enzyme for preparing lysine A and application thereof.
背景技术Background technique
甜菊糖(Steviol glycoside),又名甜菊糖苷,是一种低热量高倍甜味剂,其甜度为蔗糖的150-300倍,热量约为蔗糖的1/300。研究表明,具有无毒副作用,食用安全,并且研究表明甜菊糖可用于预防高血压、糖尿病、肥胖症、心脏病和龋齿等病症,是一种可替代蔗糖非常理想的甜味剂。然而,甜菊糖各组分的甜度倍数和口感参差不齐;例如主要组分之一的甜菊苷(Stevioside,St)具有后苦味和余味,极大地局限了其应用;而莱苞迪甙A(Rebaudioside A,RA)在甜度、热量和理化性质上均优于甜菊苷,而且口感最接近蔗糖。Steviol glycoside, also known as stevioside, is a low-calorie, high-intensity sweetener with a sweetness 150-300 times that of sucrose and about 1/300 of that of sucrose. Studies have shown that it has no toxic side effects, is safe to eat, and studies have shown that stevioside can be used to prevent high blood pressure, diabetes, obesity, heart disease and dental caries, and is an ideal sweetener for replacing sucrose. However, the sweetness multiples and mouthfeel of the components of stevioside are uneven; for example, Stevioside (St), one of the main components, has a post-bitter taste and aftertaste, which greatly limits its application; and Lai Di Di A (Rebaudioside A, RA) is superior to stevioside in sweetness, calories and physicochemical properties, and the taste is closest to sucrose.
现有技术中,莱苞迪甙A生产方法大多集中在培育高产莱鲍迪苷A的甜叶菊品种、树脂吸附或重结晶提纯莱鲍迪苷A,或使用环糊精转移酶等酶对甜菊糖进行改性。然而上述工艺步骤繁琐,能耗高,污染大,纯度与产率均偏低。因此,有必要发展一种工艺简单、成本低、产率高且绿色环保的莱苞迪甙A的制备方法。In the prior art, most of the production methods of Laiwudi A concentrate on cultivating high-yield rebaudioside A stevia variety, resin adsorption or recrystallization to regenerate rebaudioside A, or using cyclodextrin transferase and other enzymes on stevia The sugar is modified. However, the above process steps are cumbersome, high in energy consumption, high in pollution, and low in purity and yield. Therefore, it is necessary to develop a preparation method of Lai Di Di A, which is simple in process, low in cost, high in yield, and environmentally friendly.
发明内容Summary of the invention
为了解决上述技术问题,本发明提供了莱苞迪甙A的制备方法、莱苞迪甙A制备用酶及应用;该制备方法工艺简单、产量高、成本低和绿色安全。In order to solve the above technical problems, the present invention provides a preparation method of Lai Di Di A, an enzyme for preparing Lai Di Di A and an application thereof; the preparation method has the advantages of simple process, high yield, low cost and green safety.
第一方面,本发明提供了莱苞迪甙A的制备方法,包括:In a first aspect, the present invention provides a method of preparing lysine A, comprising:
在二磷酸尿苷葡萄糖(Uridine diphosphate glucose,UDPG)和葡萄糖基转移酶存在下,以甜菊糖原料为底物配制反应液,调节所述反应液的pH为6.0-8.0, 在恒定温度20-45℃下进行搅拌反应后,收集得到莱苞迪甙A;所述甜菊糖原料包括甜菊苷,所述葡萄糖基转移酶的氨基酸序列包括如SEQ ID NO:1所示的氨基酸序列。本发明所述葡萄糖基转移酶来源于栀子花(Gardenia jasminoides)。所述二磷酸尿苷葡萄糖(UDPG)也可称为尿苷-5'-二磷酸葡萄糖或尿苷二磷酸葡萄糖。In the presence of Uridine diphosphate glucose (UDPG) and glucosyltransferase, the reaction solution is prepared by using the stevioside raw material as a substrate, and the pH of the reaction solution is adjusted to 6.0-8.0 at a constant temperature of 20-45. After the stirring reaction is carried out at ° C, the rebaudioside A is collected; the stevioside raw material includes stevioside, and the amino acid sequence of the glucosyltransferase includes the amino acid sequence shown in SEQ ID NO: 1. The glucosyltransferase of the present invention is derived from Gardenia jasminoides. The uridine diphosphate glucose (UDPG) may also be referred to as uridine-5'-diphosphate glucose or uridine diphosphate glucose.
本发明中,所述甜菊苷(St),或称甜菊甙,分子式为C 38H 60O 18,化学结构如式Ⅰ所示。所述莱苞迪甙A(RA),或称甜菊A苷、A苷甜菊糖,分子式为C 44H 70O 23,化学结构如式Ⅱ所示: In the present invention, the stevioside (St), or stevioside, has a molecular formula of C 38 H 60 O 18 and has a chemical structure as shown in Formula I. The Lydia A (RA), or stevioside A, A-side stevioside, has the formula C 44 H 70 O 23 , and the chemical structure is as shown in Formula II:
Figure PCTCN2018096211-appb-000001
Figure PCTCN2018096211-appb-000001
本发明中,所述莱苞迪甙A的制备方法的工艺路线如式(1)所示:In the present invention, the process route of the preparation method of the rebaudioside A is as shown in the formula (1):
Figure PCTCN2018096211-appb-000002
Figure PCTCN2018096211-appb-000002
其中,所述甜菊糖原料包括甜菊苷(St),所述甜菊苷和所述二磷酸尿苷葡萄糖经葡萄糖基转移酶的催化作用下得到莱苞迪甙A(RA),而所述二磷酸尿苷葡萄糖在反应中生成尿苷二磷酸(Uridine triphosphate,UDP)。所述尿苷二磷酸 也可称为尿苷-5'-二磷酸。Wherein the stevioside raw material comprises stevioside (St), and the stevioside and the uridine diphosphate glucose are catalyzed by a glucosyltransferase to obtain rebaudioside A (RA), and the diphosphate Uridine glucose forms Uridine triphosphate (UDP) in the reaction. The uridine diphosphate may also be referred to as uridine-5'-diphosphate.
可选地,所述反应液中的所述二磷酸尿苷葡萄糖通过在所述反应液中直接加入或通过在所述反应液中加入混合原料获得,所述混合原料包括尿苷二磷酸(UDP)和所述二磷酸尿苷葡萄糖中的一种或两种、蔗糖(Sucrose)和蔗糖合成酶(Sucrose Synthase,SuS)。例如,所述混合原料包括尿苷二磷酸、二磷酸尿苷葡萄糖、蔗糖和蔗糖合成酶,或所述混合原料包括二磷酸尿苷葡萄糖、蔗糖和蔗糖合成酶,或所述混合原料包括尿苷二磷酸、蔗糖和蔗糖合成酶。所述所述蔗糖合成酶(SuS),又称蔗糖合酶,是植物中广泛存在的一种糖基转移酶。Alternatively, the uridine diphosphate glucose in the reaction liquid is obtained by directly adding in the reaction liquid or by adding a mixed raw material to the reaction liquid, the mixed raw material including uridine diphosphate (UDP) And one or both of the uridine diphosphate glucose, Sucrose and Sucrose Synthase (SuS). For example, the mixed raw material includes uridine diphosphate, uridine diphosphate glucose, sucrose, and sucrose synthase, or the mixed raw material includes uridine diphosphate glucose, sucrose, and sucrose synthase, or the mixed raw material includes uridine Diphosphate, sucrose and sucrose synthase. The sucrose synthase (SuS), also known as sucrose synthase, is a glycosyltransferase widely present in plants.
可选地,所述莱苞迪甙A的制备方法的工艺路线还可以如式(2)所示:Alternatively, the process route of the preparation method of the rebaudioside A may also be as shown in the formula (2):
Figure PCTCN2018096211-appb-000003
Figure PCTCN2018096211-appb-000003
其中,所述尿苷二磷酸、所述蔗糖和所述蔗糖合成酶可以在所述反应液中反应得到所述二磷酸尿苷葡萄糖并形成所述二磷酸尿苷葡萄糖的循环再生体系;所述甜菊苷在所述葡萄糖基转移酶的催化作用下制备得到莱苞迪甙A,所述葡萄糖基转移酶能够在所述甜菊糖苷的13位的碳原子的糖基上再引入一葡糖糖基;所述蔗糖在所述蔗糖合成酶的催化下生成果糖。Wherein the uridine diphosphate, the sucrose and the sucrose synthase are reacted in the reaction solution to obtain the uridine diphosphate glucose and form the uridine diphosphate glucose regeneration system; The stevioside is prepared by the catalysis of the glucosyltransferase, and the glucosyltransferase is capable of reintroducing a glucosyl group on the sugar group of the carbon atom at the 13 position of the stevioside The sucrose produces fructose catalyzed by the sucrose synthase.
可选地,所述葡萄糖基转移酶的基因编码序列包括如SEQ ID NO:2所示的核苷酸序列。可选的,所述葡萄糖基转移酶的氨基酸序列的基因编码序列应该考虑简并碱基,即如SEQ ID NO:1所示的氨基酸序列的编码基因包括如SEQ ID  NO:2所示的核苷酸序列,保护范围还应该保护与SEQ ID NO:2具有碱基简并性质的核苷酸序列,这些核苷酸序列对应的氨基酸序列仍然为SEQ ID NO:1。Alternatively, the gene coding sequence of the glucosyltransferase comprises the nucleotide sequence set forth in SEQ ID NO: 2. Alternatively, the gene coding sequence of the amino acid sequence of the glucosyltransferase should consider a degenerate base, ie, the coding gene of the amino acid sequence shown in SEQ ID NO: 1 includes the nucleus as shown in SEQ ID NO: The nucleotide sequence, the protective range should also protect the nucleotide sequence having the base degenerate property of SEQ ID NO: 2, and the amino acid sequence corresponding to these nucleotide sequences is still SEQ ID NO: 1.
可选地,当所述混合原料包括尿苷二磷酸、蔗糖和蔗糖合成酶时,所述尿苷二磷酸、所述蔗糖和所述蔗糖合成酶的质量比为(0.0001-0.04):(0.1-2):(0.1-1)。进一步地,可选地,所述尿苷二磷酸、所述蔗糖和所述蔗糖合成酶的质量比为(0.005-0.01):1:(0.2-1)。Optionally, when the mixed raw material comprises uridine diphosphate, sucrose and sucrose synthase, the mass ratio of the uridine diphosphate, the sucrose and the sucrose synthase is (0.0001-0.04): (0.1 -2): (0.1-1). Further, optionally, the mass ratio of the uridine diphosphate, the sucrose and the sucrose synthase is (0.005-0.01): 1: (0.2-1).
可选地,当所述反应液中的所述二磷酸尿苷葡萄糖通过在所述反应液中直接加入时,所述二磷酸尿苷葡萄糖和所述甜菊苷的质量比为(0.001-1):1。进一步地,可选地,所述二磷酸尿苷葡萄糖和所述甜菊苷的质量比为(0.01-0.3):1。Alternatively, when the uridine diphosphate glucose in the reaction solution is directly added to the reaction solution, the mass ratio of the uridine diphosphate glucose to the stevioside is (0.001-1) :1. Further, optionally, the mass ratio of the uridine diphosphate glucose to the stevioside is (0.01-0.3):1.
可选地,当所述混合原料包括所述二磷酸尿苷葡萄糖、蔗糖和蔗糖合成酶时,由于所述二磷酸尿苷葡萄糖在所述葡萄糖基转移酶催化下在所述反应液中得到尿苷二磷酸,所述蔗糖、所述蔗糖合成酶和是尿苷二磷酸可以反应生成二磷酸尿苷葡萄糖,并在所述反应液中形成所述二磷酸尿苷葡萄糖的循环再生体系。可选地,所述蔗糖合成酶来源于拟南芥、大豆和马铃薯中的一种或多种。进一步地,可选地,所述蔗糖合成酶来源于拟南芥。Optionally, when the mixed raw material includes the uridine diphosphate glucose, sucrose, and sucrose synthase, the uridine diphosphate glucose is catalyzed by the glucosyltransferase to obtain urine in the reaction solution. The glycoside diphosphate, the sucrose, the sucrose synthase, and the uridine diphosphate can be reacted to form uridine diphosphate glucose, and a cyclic regeneration system of the uridine diphosphate glucose is formed in the reaction solution. Alternatively, the sucrose synthase is derived from one or more of Arabidopsis thaliana, soybeans, and potatoes. Further, optionally, the sucrose synthase is derived from Arabidopsis thaliana.
可选地,所述甜菊糖原料在所述反应液中的质量分数为10%-30%。进一步地,可选地,所述甜菊糖原料在所述反应液中的质量分数为20%-30%。例如,所述甜菊糖原料在所述反应液中的质量分数为10%,或为18%,或为25%,或为30%。Optionally, the stevioside raw material has a mass fraction of 10%-30% in the reaction solution. Further, optionally, the mass fraction of the stevioside raw material in the reaction liquid is 20% to 30%. For example, the stevioside raw material has a mass fraction of 10%, or 18%, or 25%, or 30% in the reaction liquid.
可选地,所述甜菊糖原料与所述葡萄糖基转移酶的质量比为1:(0.1-1);所述葡萄糖基转移酶的添加形式包括粗酶液或酶粉。所述葡萄糖基转移酶的粗酶液是指含有葡萄糖基转移酶的微生物破碎缓冲液,所述微生物可以合成所述葡萄糖基转移酶。所述葡萄糖基转移酶的酶粉是指所述葡萄糖基转移酶纯化后的 冷冻干燥酶粉。Optionally, the mass ratio of the stevioside raw material to the glucosyltransferase is 1: (0.1-1); the added form of the glucosyltransferase comprises a crude enzyme solution or an enzyme powder. The crude enzyme solution of the glucosyltransferase refers to a microorganism disruption buffer containing a glucosyltransferase, and the microorganism can synthesize the glucosyltransferase. The enzyme powder of the glucosyltransferase refers to a freeze-dried enzyme powder obtained by purifying the glucosyltransferase.
可选地,所述反应液的反应温度维持在20-45℃。进一步地,可选地,所述反应液的反应温度维持在35-40℃。例如,所述反应液的反应温度维持在20℃,或为30℃,或为35℃,或为38℃,或为40℃。所述温度范围下的所述葡萄糖基转移酶的催化活性高,所述甜菊苷的转化率高。Alternatively, the reaction temperature of the reaction liquid is maintained at 20 to 45 °C. Further, optionally, the reaction temperature of the reaction liquid is maintained at 35 to 40 °C. For example, the reaction temperature of the reaction liquid is maintained at 20 ° C, or 30 ° C, or 35 ° C, or 38 ° C, or 40 ° C. The glucosyltransferase has a high catalytic activity at the temperature range, and the conversion rate of the stevioside is high.
进一步地,可选地,本发明所述制备方法中,调节所述反应液的pH为7.0-8.0。例如,调节所述反应液的pH为7.2,或为7.4,或为8.0。Further, optionally, in the preparation method of the present invention, the pH of the reaction solution is adjusted to be 7.0 to 8.0. For example, the pH of the reaction solution is adjusted to 7.2, or 7.4, or 8.0.
可选地,所述搅拌反应的反应时间为4-25小时。所述搅拌反应的搅拌速率为200-300rpm。进一步地,可选地,所述搅拌反应的反应时间为10-20小时。例如,所述搅拌反应的反应时间为4小时,或为10小时,或为15小时,或为20小时。Optionally, the reaction time of the stirring reaction is 4-25 hours. The stirring reaction is stirred at a rate of 200-300 rpm. Further, optionally, the reaction time of the stirring reaction is 10-20 hours. For example, the reaction time of the stirring reaction is 4 hours, or 10 hours, or 15 hours, or 20 hours.
可选地,所述收集得到莱苞迪甙A的过程包括:对所述反应液加热以使所述葡萄糖基转移酶变性,过滤并收集滤液,将所述滤液纯化处理后得到莱苞迪甙A,其中,所述加热的温度为85-100℃,时间为0.3-1小时。所述莱苞迪甙A在纯化处理过程中会存在部分损失,纯化处理后得到的所述莱苞迪甙A的甜度、热量和理化性质均符合实际理论参数。Optionally, the process of collecting the rebaudioside A comprises: heating the reaction solution to denature the glucosyltransferase, filtering and collecting the filtrate, and purifying the filtrate to obtain Lai Didi A, wherein the heating temperature is 85-100 ° C and the time is 0.3-1 hour. The rebaudioside A may have partial loss during the purification treatment, and the sweetness, heat and physical and chemical properties of the rebaudioside A obtained after the purification treatment are in accordance with actual theoretical parameters.
可选地,所述反应液至少包括二磷酸尿苷葡萄糖再生体系时,所述甜菊苷与所述蔗糖的质量比为1:(0.2-1)。Optionally, when the reaction solution comprises at least a uridine diphosphate glucose regeneration system, the mass ratio of the stevioside to the sucrose is 1: (0.2-1).
可选地,所述反应液中还包括缓冲液,所述缓冲液包括磷酸盐缓冲液、硼酸盐缓冲液和Tris-HCl缓冲液中的一种或多种。可选地,所述缓冲液的浓度为10-500mmol/L。进一步地,可选地,所述缓冲液的浓度为100-500mmol/L。例如,所述缓冲液的浓度为100mmol/L,或为200mmol/L,或为500mmol/L。可选地,所述缓冲液还包括其他种类缓冲液。Optionally, the reaction solution further includes a buffer, and the buffer includes one or more of a phosphate buffer solution, a borate buffer solution, and a Tris-HCl buffer solution. Alternatively, the concentration of the buffer is 10-500 mmol/L. Further, optionally, the concentration of the buffer is 100-500 mmol/L. For example, the concentration of the buffer is 100 mmol/L, or 200 mmol/L, or 500 mmol/L. Optionally, the buffer also includes other types of buffers.
本发明第一方面所提供的莱苞迪甙A的制备方法,工艺简单,成本低廉,绿 色环保;所述莱苞迪甙A具有极高的产率。相比于现有技术中的10-60%转化率,本发明所述制备方法的转化率高达90%以上,甚至达到99%。现有技术中莱苞迪甙A的制备方法只能利用千分之几底物浓度,加之转化率低;即使通过补加原料等方式,转化率的提高幅度仍然有限,因此,现有技术整体的成本偏高,不利于工业化生产。本发明所述制备方法,未使用大量有机试剂,并且本发明所述底物浓度可以高达10-30%,同时可以通过二磷酸尿苷葡萄糖再生体系用来循环得到原料成本较高的二磷酸尿苷葡萄糖(UDPG);因此,本发明所述制备方法成本低廉,绿色环保,纯化步骤少,具有很大的应用前景。The preparation method of the rebaudioside A provided by the first aspect of the invention has the advantages of simple process, low cost and green environmental protection; and the rebaudioside A has an extremely high yield. Compared to the 10-60% conversion rate in the prior art, the conversion rate of the preparation method of the present invention is as high as 90% or even 99%. In the prior art, the preparation method of Lai Di Di A can only use a substrate concentration of a few thousandths, and the conversion rate is low; even if the raw material is added by a method such as adding raw materials, the conversion rate is still limited, and therefore, the prior art as a whole The high cost is not conducive to industrial production. The preparation method of the invention does not use a large amount of organic reagents, and the concentration of the substrate of the invention can be as high as 10-30%, and can be used to recycle the diphosphate urine with high raw material cost through the uridine diphosphate glucose regeneration system. Glycoside Glucose (UDPG); Therefore, the preparation method of the invention has low cost, is environmentally friendly, has few purification steps, and has great application prospects.
第二方面,本发明还提供了一种莱苞迪甙A的制备用酶,所述制备用酶为葡萄糖基转移酶,所述葡萄糖基转移酶的基因编码序列包括如SEQ ID NO:2所示的核苷酸序列。可选地,所述葡萄糖基转移酶的氨基酸序列包括如SEQ ID NO:1所示的氨基酸序列。In a second aspect, the present invention provides an enzyme for preparing rebaudioside A, wherein the enzyme for preparation is a glucosyltransferase, and the gene coding sequence of the glucosyltransferase comprises SEQ ID NO: 2 The nucleotide sequence shown. Alternatively, the amino acid sequence of the glucosyltransferase comprises the amino acid sequence set forth in SEQ ID NO: 1.
可选地,所述葡萄糖基转移酶通过微生物表达生成,所述微生物包括大肠杆菌、毕赤酵母和枯草芽孢杆菌中的一种或多种。进一步地,可选地,所述葡萄糖基转移酶通过大肠杆菌表达生成。所述葡萄糖基转移酶在所述大肠杆菌表达生成的体系中均属于异源表达。本发明优选地大肠杆菌表达系统,简单可行,培养周期短,发酵成本低,酶产量高。本发明所述葡萄糖基转移酶可以以酶粉形式或粗酶液形式添加至所述反应液中。Alternatively, the glucosyltransferase is produced by microbial expression, including one or more of Escherichia coli, Pichia pastoris, and Bacillus subtilis. Further, optionally, the glucosyltransferase is produced by expression in E. coli. The glucosyltransferase is heterologously expressed in the system in which the E. coli expression is expressed. The present invention preferably has an E. coli expression system which is simple and feasible, has a short culture period, low fermentation cost, and high enzyme yield. The glucosyltransferase of the present invention may be added to the reaction solution in the form of an enzyme powder or a crude enzyme solution.
本发明所述葡萄糖基转移酶来源于栀子花,是通过大量实验筛选得到所述葡萄糖基转移酶的基因编码序列,并通过优化微生物表达体系纯化得到。由于不同种属来源的葡萄糖基转移酶的酶学性质存在差异,包括酶的比活性、酶作用的底物范围、最适pH、最适温度、作用时间和酶的稳定性等方面。同时,来自相同种属的具有相同名称的酶的酶学性质也存在巨大差异;例如本发明通过 实验发现来源于栀子花的另一种葡萄糖基转移酶不具有催化甜菊苷转化成莱苞迪甙A的功能。所述本发明所述葡萄糖基转移酶具有极强的专一性,可以高效地所述甜菊糖苷催化得到所述莱苞迪甙A。可选地,所述甜菊糖原料还可以为包括甜菊苷为主要成份的混合物,本发明所述的葡萄糖基转移酶可以高效专一的催化所述甜菊苷转化为莱苞迪甙A。The glucosyltransferase of the present invention is derived from gardenia, and the gene coding sequence of the glucosyltransferase is screened by a large number of experiments and purified by optimizing the microbial expression system. The enzymatic properties of glucosyltransferases from different species are different, including the specific activity of the enzyme, the substrate range of the enzyme, the optimum pH, the optimum temperature, the action time and the stability of the enzyme. At the same time, the enzymatic properties of enzymes with the same name from the same species are also greatly different; for example, the present invention finds that another glucosyltransferase derived from gardenia does not have the catalytic conversion of stevioside to Laiwudi.甙A's function. The glucosyltransferase of the present invention has extremely strong specificity, and the rebaudioside A can be efficiently catalyzed by the stevioside. Alternatively, the stevioside raw material may further be a mixture comprising stevioside as a main component, and the glucosyltransferase of the present invention can efficiently and specifically catalyze the conversion of the stevioside to rebaudioside A.
可选地,所述葡萄糖基转移酶通过构建重组质粒在微生物中表达,所述重组质粒的载体质粒为pET28a(+)载体质粒。将所述葡萄糖基转移酶的基因编码序列插入至所述pET28a(+)载体质粒中得到重组质粒,所述重组质粒可以高效、高产的在微生物细胞中的异源表达得到所述葡萄糖基转移酶。Alternatively, the glucosyltransferase is expressed in a microorganism by constructing a recombinant plasmid whose vector plasmid is a pET28a(+) vector plasmid. Inserting the gene coding sequence of the glucosyltransferase into the pET28a(+) vector plasmid to obtain a recombinant plasmid capable of efficiently and efficiently producing heterologous expression in a microbial cell to obtain the glucosyltransferase .
可选地,所述葡萄糖基转移酶的基因编码序列上增设His标签(组氨酸标签)的核苷酸序列,能使表达后的蛋白带上His标签,His标签有利于表达后蛋白的分离纯化,及在实验中的分析和追踪,比如用于免疫印迹实验时的分析。Optionally, the nucleotide sequence of the His-tag (histidine tag) is added to the gene coding sequence of the glucosyltransferase, and the expressed protein is tagged with His tag, and the His tag is favorable for separation of the expressed protein. Purification, and analysis and tracing in experiments, such as for analysis in immunoblot experiments.
可选地,所述葡萄糖基转移酶的基因编码序列插入到pET28a(+)载体质粒的BamH I和Hind III酶切位点之间。所述葡萄糖基转移酶的基因编码序列插入到pET28a(+)载体质粒时,所述葡萄糖基转移酶的基因编码序列的5’端可加入起始密码子(如ATG)与pET28a(+)载体质粒中BamHⅠ酶切位点相连,3’端可加入终止密码子(如TAA)与pET28a(+)载体质粒中Hind III酶切位点相连。Alternatively, the gene coding sequence for the glucosyltransferase is inserted between the BamH I and Hind III restriction sites of the pET28a(+) vector plasmid. When the gene coding sequence of the glucosyltransferase is inserted into the pET28a(+) vector plasmid, the 5' end of the gene coding sequence of the glucosyltransferase may be added with a start codon (such as ATG) and a pET28a (+) vector. The BamHI restriction site is ligated in the plasmid, and the stop codon (such as TAA) can be added to the 3' end to be ligated with the Hind III restriction site in the pET28a(+) vector plasmid.
第三方面,本发明还提供了葡萄糖基转移酶以及含有所述葡萄糖基转移酶的基因的微生物菌株在生物催化中的应用,所述葡萄糖基转移酶的氨基酸序列包括如SEQ ID NO:1所示的氨基酸序列;所述葡萄糖基转移酶催化甜菊苷转化成莱苞迪甙A。可选地,所述葡萄糖基转移酶由来源于栀子花的葡萄糖基转移酶基因编码,所述葡萄糖基转移酶的基因编码序列包括如SEQ ID NO:2所示的核苷酸序列。In a third aspect, the present invention also provides a biocatalytic use of a glucosyltransferase and a microorganism strain comprising the gene of the glucosyltransferase, the amino acid sequence of the glucosyltransferase comprising SEQ ID NO: The amino acid sequence shown; the glucosyltransferase catalyzes the conversion of stevioside to rebaudioside A. Alternatively, the glucosyltransferase is encoded by a glucosyltransferase gene derived from gardenia, and the gene coding sequence of the glucosyltransferase comprises the nucleotide sequence set forth in SEQ ID NO: 2.
本发明的有益效果包括以下几个方面:The beneficial effects of the present invention include the following aspects:
1、本发明所述莱苞迪甙A的制备方法为生物酶法,该制备方法简单高效,成本低,转化率高和绿色安全,可以广泛适用于工业化规模生产;1. The preparation method of the rebaudioside A according to the invention is a biological enzymatic method, the preparation method is simple and efficient, low in cost, high in conversion rate and green in safety, and can be widely applied to industrial scale production;
2、本发明所述的制备方法,底物(甜菊糖原料)的终浓度远远大于现有技术,底物的终浓度可高到达10%-30%;2. The preparation method according to the present invention, the final concentration of the substrate (stevioside raw material) is far greater than the prior art, and the final concentration of the substrate can reach 10%-30%;
3、由本发明所述的制备方法制得的所述莱苞迪甙A,纯度高,产量高,可广泛应用在食品工业及制药领域;3. The Laiwudi A obtained by the preparation method of the invention has high purity and high yield and can be widely applied in the food industry and the pharmaceutical field;
4、本发明所述莱苞迪甙A的制备方法的制备用酶—葡萄糖基转移酶,特异性强,能够高效地将所述甜菊苷转化生成莱苞迪甙A。4. The preparation method of the preparation method of the rebaudioside A of the present invention is characterized in that the enzyme-glucosyltransferase is highly specific and can efficiently convert the stevioside to the rebaudioside A.
附图说明DRAWINGS
图1为本发明一实施例提供的pET28a-RA07重组质粒的质粒图谱。1 is a plasmid map of a recombinant plasmid pET28a-RA07 according to an embodiment of the present invention.
具体实施方式Detailed ways
以下所述是本发明实施例的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明实施例原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也视为本发明实施例的保护范围。The following are the preferred embodiments of the embodiments of the present invention, and it should be noted that those skilled in the art can make some improvements and refinements without departing from the principles of the embodiments of the present invention. And retouching is also considered to be the scope of protection of the embodiments of the present invention.
若无特别说明,本发明实施例所采用的原料及其它化学试剂皆为市售商品。Unless otherwise stated, the raw materials and other chemical reagents used in the examples of the present invention are all commercially available.
(1)构建重组质粒(1) Construction of recombinant plasmid
a)提供上游引物和下游引物,通过实验得到葡萄糖基转移酶(RA07);所述葡萄糖基转移酶(RA07)的基因编码序列包括如SEQ ID NO:2所示的核苷酸序列,所述葡萄糖基转移酶的氨基酸序列包括如SEQ ID NO:1所示的氨基酸序列;所述葡萄糖基转移酶来源于栀子花。a) providing an upstream primer and a downstream primer, and obtaining a glucosyltransferase (RA07) by experiments; the gene coding sequence of the glucosyltransferase (RA07) comprises a nucleotide sequence as shown in SEQ ID NO: 2, The amino acid sequence of the glucosyltransferase comprises the amino acid sequence set forth in SEQ ID NO: 1; the glucosyltransferase is derived from gardenia.
b)将所述RA07的基因编码序列插入到pET28a(+)载体质粒的BamH I和Hind III酶切位点之间。所述RA07的基因编码序列插入到pET28a(+)载体质粒 时,所述RA07的基因编码序列的5’端添加起始密码子(如ATG)与pET28a(+)载体质粒中BamH Ⅰ酶切位点相连,3’端还添加有终止密码子(如TAA)与pET28a(+)载体质粒中Hind III酶切位点相连。然后转入大肠杆菌感受态细胞DH5α,进行阳性克隆PCR鉴定和测序鉴定。经过PCR产物凝胶电泳检测和测序鉴定符合目的片段大小和序列,成功构建pET28a-RA07重组质粒。如图1是所示为pET28a-RA07重组质粒图谱。b) Inserting the gene coding sequence of RA07 between the BamH I and Hind III restriction sites of the pET28a(+) vector plasmid. When the gene coding sequence of RA07 is inserted into the pET28a(+) vector plasmid, the 5' end of the gene coding sequence of RA07 is added with a start codon (such as ATG) and a BamH I cleavage site in the pET28a(+) vector plasmid. The points are ligated, and a stop codon (such as TAA) is added to the 3' end to be ligated to the Hind III restriction site in the pET28a(+) vector plasmid. Then, it was transferred into E. coli competent cell DH5α, and positive clone PCR identification and sequencing were performed. The recombinant plasmid pET28a-RA07 was successfully constructed by PCR product gel electrophoresis detection and sequencing to identify the size and sequence of the target fragment. Figure 1 is a representation of the recombinant plasmid pET28a-RA07.
(2)葡萄糖基转移酶的表达(2) Expression of glucosyltransferase
将构建的重组质粒pET28a-RA07转入大肠杆菌BL21(DE3)中,并以1%的接种量接种至含有4mL的LB培养基中,维持恒定的37℃,200rpm的摇晃速率,过夜培养后,将菌液以1%的接种量转接到含有1L的LB培养基(50μg/mL卡那霉素)的2L三角瓶中,继续37℃恒温培养至培养基中的OD600值达到0.6左右,加入终浓度为度0.1mM-1mM的诱导剂IPTG,在20-37℃条件培养12-16小时后离心收集菌体。将菌体用50mM磷酸缓冲液(pH=7.4)进行重悬并经超声破碎和离心,收集上清液得到含有RA07的粗酶液。The constructed recombinant plasmid pET28a-RA07 was transferred into E. coli BL21 (DE3), and inoculated into 4 mL of LB medium at a 1% inoculation amount, maintaining a constant 37 ° C, shaking rate of 200 rpm, after overnight culture. Transfer the bacterial solution to a 2L flask containing 1L of LB medium (50μg/mL kanamycin) at 1% inoculation, and continue to incubate at 37 °C until the OD600 value in the medium reaches 0.6 or so. The inducer IPTG was used at a final concentration of 0.1 mM to 1 mM, and cultured at 20-37 ° C for 12-16 hours, and then the cells were collected by centrifugation. The cells were resuspended in 50 mM phosphate buffer (pH = 7.4), sonicated and centrifuged, and the supernatant was collected to obtain a crude enzyme solution containing RA07.
将表达获得的含有RA07的粗酶液进行SDS-聚丙烯酰胺凝胶电泳(SDS-PAGE)鉴定。本实施方式表达获得的粗酶液中,所述RA07的分子大小与理论计算值相符合,所述RA07的理论分子量为53KD。此外,对收集得到的粗酶液进行冷冻干燥,可进一步制得RA07的酶粉。The obtained crude enzyme solution containing RA07 was identified by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). In the crude enzyme solution obtained by the present embodiment, the molecular size of the RA07 is in agreement with a theoretically calculated value, and the theoretical molecular weight of the RA07 is 53 KD. Further, the collected enzyme solution is freeze-dried to further prepare an enzyme powder of RA07.
(3)葡萄糖基转移酶的筛选(3) Screening of glucosyltransferase
a)通过实验得到的来源于不同种属的葡萄糖基转移酶RA01-RA11;其中,每个所述葡萄糖基转移酶的具体来源参见下表;其中,RA01来源于甜叶菊(Stevia rebaudiana),RA02来源于向日葵(Helianthus annuus),RA03来源于水稻(Oryza sativa),RA04来源于二穗短柄草(Brachypodium distachyon),RA05 来源于甜叶菊(Stevia rebaudiana),RA06来源于萝芙木(Rauvolfia serpentina),RA07来源于栀子花(Gardenia jasminoides),RA08来源于长春花(Catharanthus roseus),RA09来源于栀子花(Gardenia jasminoides),RA10来源于胡黄连(Picrorhiza kurrooa),RA11来源于乳杆菌(Lactobacillus reuteri 180),RA12来源于大麦(Hordeum vulgare subsp.Vulgare);a) glucosyltransferases RA01-RA11 derived from different species obtained by experiments; wherein, the specific source of each of the glucosyltransferases is shown in the following table; wherein RA01 is derived from Stevia rebaudiana, RA02 From sunflower (Helianthus annuus), RA03 from rice (Oryza sativa), RA04 from Brachypodium distachyon, RA05 from Stevia rebaudiana, RA06 from Rauvolfia serpentina RA07 is derived from Gardenia jasminoides, RA08 is derived from Catharanthus roseus, RA09 is derived from Gardenia jasminoides, RA10 is derived from Picrorhiza kurrooa, and RA11 is derived from Lactobacillus. Reuteri 180), RA12 is derived from barley (Hordeum vulgare subsp. Vulgare);
b)基本按照上述步骤(1)及步骤(2)的操作过程,构建上述葡萄糖基转移酶RA01-RA11分别对应的的重组质粒,得到RA系列的重组质粒,将所述RA系列的重组质粒转化进入大肠杆菌BL21(DE3)中,利用IPTG诱导目的蛋白表达,调控最适的诱导剂用量和酶表达温度,得到RA系列的重组大肠杆菌表达菌株;并进一步得到RA系列的重组大肠杆菌的粗酶液;b) constructing the recombinant plasmid corresponding to the above glucosyltransferase RA01-RA11 according to the above steps (1) and (2), and obtaining a recombinant plasmid of the RA series, and transforming the recombinant plasmid of the RA series. Entering E. coli BL21 (DE3), using IPTG to induce the expression of the target protein, regulating the optimal amount of inducer and enzyme expression temperature, and obtaining the recombinant E. coli expression strain of RA series; and further obtaining the crude enzyme of recombinant Escherichia coli of RA series liquid;
c)设计反应体系:在1mL的磷酸钠缓冲液中,分别加入甜菊苷5mg、UDPG5mg,搅拌至完全溶解;继续加入上述RA系列的重组大肠杆菌的粗酶液(包括RA01-RA11)中的任意一种葡萄糖基转移酶的粗酶液200μL(50mg),调节pH至7.4;在37℃、250rpm转速下反应16h,并检测并收集莱苞迪甙A,计算转化率并评估每种葡萄糖基转移酶的酶活情况,见下表所示:c) Design the reaction system: add 1 mg of stevioside and 5 mg of UDPG in 1 mL of sodium phosphate buffer, stir until completely dissolved; continue to add any of the above-mentioned RA series of recombinant Escherichia coli crude enzyme solution (including RA01-RA11) A crude enzyme solution of glucose-transferase 200 μL (50 mg), adjusted to pH 7.4; reacted at 37 ° C, 250 rpm for 16 h, and detected and collected rebaudioside A, calculated conversion rate and evaluated each glucosyltransfer The enzymatic activity of the enzyme is shown in the table below:
Figure PCTCN2018096211-appb-000004
Figure PCTCN2018096211-appb-000004
实验结果表明,不同种属来源的葡萄糖基转移酶的酶学性质存在巨大差异,其中,RA02-RA06、RA08-RA12均基本不具有酶活性,不能催化甜菊苷转化成莱苞迪甙A,RA01的酶活性较低,催化效果较差,而RA07具有极高的酶活性,催化性能强,转化率高达99%,可以高效地所述甜菊糖苷催化得到所述莱苞迪甙A;同时,来自相同种属的酶的酶学性质也存在巨大差异,例如RA01和RA05都来源于甜叶菊,以及RA07和RA09都来源于栀子花,但两者的催化性能差别巨大。本实施方式中,所述转化率是在所述搅拌反应结束后通过液相色谱测定反应液中的甜菊苷含量后进行计算得到。The results showed that the enzymatic properties of glucosyltransferases from different species were significantly different. Among them, RA02-RA06 and RA08-RA12 had no enzymatic activity and could not catalyze the conversion of stevioside to Laiwudi A, RA01. The enzyme activity is low, the catalytic effect is poor, and RA07 has extremely high enzymatic activity, strong catalytic performance, and the conversion rate is as high as 99%, and the stevioside can be efficiently catalyzed to obtain the rebaudioside A; The enzymatic properties of the enzymes of the same species are also greatly different. For example, both RA01 and RA05 are derived from stevia, and both RA07 and RA09 are derived from gardenia, but the catalytic properties of the two are greatly different. In the present embodiment, the conversion rate is calculated by measuring the stevioside content in the reaction liquid by liquid chromatography after completion of the stirring reaction.
实施例1Example 1
一种莱苞迪甙A的制备方法,包括:A method for preparing Lai Di Di A, comprising:
在磷酸钠缓冲液中,分别加入甜菊苷100g、蔗糖80g和UDP1g,搅拌至完全溶解;继续加入葡萄糖基转移酶RA07酶粉50g和蔗糖合成酶(来源于拟南芥,NP_197583)50g,反应总体系体积为1L,调节体系pH至7.4;在恒温37℃、200rpm搅拌速率下反应16h,通过实验测得转化率为99%,反应完成后将反应液加热至100℃热处理0.5h,使RA07蛋白变性并过滤除去蛋白,收集滤液后进行喷雾干燥得到莱苞迪甙A粗品,将所述莱苞迪甙A粗品经硅胶树脂分离、结晶等后处理纯化后得到莱苞迪甙A 96.22g,纯度>95%。In the sodium phosphate buffer, 100 g of stevioside, 80 g of sucrose and 1 g of UDP were added, respectively, and stirred until completely dissolved; 50 g of glucosyltransferase RA07 enzyme powder and 50 g of sucrose synthase (derived from Arabidopsis thaliana, NP_197583) were added. The volume of the system was 1 L, and the pH of the system was adjusted to 7.4. The reaction was carried out for 16 h at a constant temperature of 37 ° C and a stirring rate of 200 rpm. The conversion was 99% by the experiment. After the reaction was completed, the reaction solution was heated to 100 ° C for 0.5 h to obtain RA07 protein. The product was denatured and filtered to remove the protein, and the filtrate was collected and spray-dried to obtain a crude product of rebaudioside A. The crude product of Lycopidiside A was separated by silica gel resin, crystallized, etc., and purified by post-treatment to obtain a lyophilized A 96.22 g. >95%.
实施例2Example 2
一种莱苞迪甙A的制备方法,包括:A method for preparing Lai Di Di A, comprising:
在磷酸钠缓冲液中,分别加入甜菊苷100g和UDPG 1.5g,搅拌至完全溶解;继续加入葡萄糖基转移酶RA07酶粉50g,反应总体系体积为1L,调节体系pH至7.4;在恒温37℃、250rpm搅拌速率下反应16h,通过实验测得转化率为99%,反应完成后将反应液加热至100℃热处理0.5h,使RA07蛋白变性并过滤除去蛋白, 收集滤液后进行喷雾干燥得到莱苞迪甙A粗品,将所述莱苞迪甙A粗品经硅胶树脂分离、结晶等后处理纯化后得到莱苞迪甙A 95.82g,纯度>95%。In the sodium phosphate buffer, add 100g of stevioside and 1.5g of UDPG, respectively, stir until completely dissolved; continue to add 50g of glucosyltransferase RA07 enzyme powder, the total volume of the reaction system is 1L, adjust the pH of the system to 7.4; at a constant temperature of 37 °C The reaction was carried out for 16 h at a stirring rate of 250 rpm. The conversion was 99% by the experiment. After the reaction was completed, the reaction solution was heated to 100 ° C for 0.5 h, and the RA07 protein was denatured and filtered to remove the protein. The filtrate was collected and spray dried to obtain Laiwu. The crude product of Dijon A was purified by post-treatment of the crude product of Lycopidine A by silica gel resin, crystallizing, etc. to obtain 95% of the lyophilized A 95.82 g, and the purity was >95%.
实施例3Example 3
一种莱苞迪甙A的制备方法,包括:A method for preparing Lai Di Di A, comprising:
在磷酸钠缓冲液中,分别加入甜菊苷100g和UDPG 1.5g,搅拌至完全溶解;继续加入葡萄糖基转移酶RA07酶粉50g,反应总体系体积为1L,调节体系pH至6.0;在恒温20℃、200rpm搅拌速率下反应16h,通过实验测得转化率为97%,反应完成后将反应液加热至100℃热处理0.5h,使RA07蛋白变性并过滤除去蛋白,收集滤液后进行喷雾干燥得到莱苞迪甙A粗品,将所述莱苞迪甙A粗品经硅胶树脂分离、结晶等后处理纯化后得到莱苞迪甙A 93.17g,纯度>95%。In the sodium phosphate buffer, add 100g of stevioside and 1.5g of UDPG, respectively, stir until completely dissolved; continue to add 50g of glucosyltransferase RA07 enzyme powder, the total volume of the reaction system is 1L, adjust the pH of the system to 6.0; at a constant temperature of 20 °C The reaction was carried out at a stirring rate of 200 rpm for 16 h, and the conversion was 97%. After the completion of the reaction, the reaction solution was heated to 100 ° C for 0.5 h, the RA07 protein was denatured and the protein was removed by filtration, and the filtrate was collected and spray-dried to obtain Laiwu. Di 甙 A crude product, the crude product of the lycopene A was separated by silica gel resin, crystallized and the like, and then purified to obtain a 93.17 g of a lyophilized product, and the purity was >95%.
实施例4Example 4
一种莱苞迪甙A的制备方法,包括:A method for preparing Lai Di Di A, comprising:
在磷酸钠缓冲液中,分别加入甜菊苷100g、蔗糖100g和UDP 0.5g,搅拌至完全溶解;继续加入葡萄糖基转移酶RA07酶粉50g和蔗糖合成酶(来源于拟南芥,NP_197583)50g,反应总体系体积为1L,调节体系pH至8.0;在恒温40℃、300rpm搅拌速率下反应8h,通过实验测得转化率为98%,反应完成后将反应液加热至100℃热处理0.5h,使RA07蛋白变性并过滤除去蛋白,收集滤液后进行喷雾干燥得到莱苞迪甙A粗品,将所述莱苞迪甙A粗品经硅胶树脂分离、结晶等后处理纯化后得到莱苞迪甙A 94.37g,纯度>95%。In the sodium phosphate buffer, 100 g of stevioside, 100 g of sucrose, and 0.5 g of UDP were added, respectively, and stirred until completely dissolved; 50 g of glucosyltransferase RA07 enzyme powder and 50 g of sucrose synthase (derived from Arabidopsis thaliana, NP_197583) were continuously added. The total volume of the reaction system was 1 L, and the pH of the system was adjusted to 8.0. The reaction was carried out for 8 h at a constant temperature of 40 ° C and a stirring rate of 300 rpm. The conversion was 98% by the experiment. After the reaction was completed, the reaction solution was heated to 100 ° C for 0.5 h. The protein of RA07 was denatured and filtered to remove the protein. The filtrate was collected and spray-dried to obtain a crude product of rebaudioside A. The crude product of rebaudioside A was separated by silica gel resin, crystallized, etc., and then purified to obtain a lyophilized A 94.37 g. , purity >95%.
实施例4Example 4
一种莱苞迪甙A的制备方法,包括:A method for preparing Lai Di Di A, comprising:
在磷酸钠缓冲液中,分别加入甜菊苷100g、蔗糖100g和UDP 0.5g,搅拌至完全溶解;继续加入葡萄糖基转移酶RA07酶粉50g和蔗糖合成酶(来源于拟 南芥,NP_197583)50g,反应总体系体积为1L,调节体系pH至7.4;在恒温45℃、300rpm搅拌速率下反应8h,通过实验测得转化率为98%,反应完成后将反应液加热至100℃热处理0.5h,使RA07蛋白变性并过滤除去蛋白,收集滤液后进行喷雾干燥得到莱苞迪甙A粗品,将所述莱苞迪甙A粗品经硅胶树脂分离、结晶等后处理纯化后得到莱苞迪甙A 95.01g,纯度>95%。In the sodium phosphate buffer, 100 g of stevioside, 100 g of sucrose, and 0.5 g of UDP were added, respectively, and stirred until completely dissolved; 50 g of glucosyltransferase RA07 enzyme powder and 50 g of sucrose synthase (derived from Arabidopsis thaliana, NP_197583) were continuously added. The total volume of the reaction system was 1 L, and the pH of the system was adjusted to 7.4. The reaction was carried out for 8 h at a constant temperature of 45 ° C and a stirring rate of 300 rpm. The conversion was 98% by the experiment. After the reaction was completed, the reaction solution was heated to 100 ° C for 0.5 h. The protein of RA07 was denatured and filtered to remove the protein. The filtrate was collected and spray-dried to obtain a crude product of rebaudioside A. The crude product of rebaudioside A was separated by silica gel resin, crystallized, etc., and purified by post-treatment to obtain Lai Di Di A 95.01 g. , purity >95%.
实施例5Example 5
一种莱苞迪甙A的制备方法,包括:A method for preparing Lai Di Di A, comprising:
在硼酸缓盐冲液中,分别加入甜菊苷200g、蔗糖120g和UDP 1.5g,搅拌至完全溶解;继续加入葡萄糖基转移酶RA07酶粉 80g和蔗糖合成酶(来源于拟南芥,NP_197583)60g,反应总体系体积为1L,调节体系pH至7.4;在恒温37℃、250rpm搅拌速率下反应20h,通过实验测得转化率为98%,反应完成后将反应液加热至100℃热处理0.5h,使RA07蛋白变性并过滤除去蛋白,收集滤液后进行喷雾干燥得到莱苞迪甙A粗品,将所述莱苞迪甙A粗品经硅胶树脂分离、结晶等后处理纯化后得到莱苞迪甙A 190.02g,纯度>95%。In boric acid buffer, 200 g of stevioside, 120 g of sucrose and 1.5 g of UDP were added, respectively, and stirred until completely dissolved; glucosyltransferase RA07 enzyme powder 80 g and sucrose synthase (from Arabidopsis thaliana, NP_197583) 60 g were continuously added. The total volume of the reaction system is 1 L, and the pH of the system is adjusted to 7.4; the reaction is carried out at a constant temperature of 37 ° C and a stirring rate of 250 rpm for 20 hours, and the conversion rate is 98% by the experiment. After the reaction is completed, the reaction liquid is heated to 100 ° C for 0.5 h. The protein of RA07 was denatured and the protein was removed by filtration, and the filtrate was collected and spray-dried to obtain a crude product of rebaudioside A. The crude product of rebaudioside A was separated by silica gel resin, crystallized, etc., and then purified to obtain a lycopene A 190.02. g, purity > 95%.
实施例6Example 6
一种莱苞迪甙A的制备方法,包括:A method for preparing Lai Di Di A, comprising:
在硼酸缓盐冲液中,分别加入甜菊苷300g、蔗糖150g和UDP 2g,搅拌至完全溶解;继续加入葡萄糖基转移酶RA07酶粉100g和蔗糖合成酶(来源于拟南芥,NP_197583)80g,反应总体系体积为1L,调节体系pH至7.4;在恒温37℃、300rpm搅拌速率下反应20h,通过实验测得转化率为96%,反应完成后将反应液加热至100℃热处理0.5h,使RA07蛋白变性并过滤除去蛋白,收集滤液后进行喷雾干燥得到莱苞迪甙A粗品,将所述莱苞迪甙A粗品经硅胶树脂分离、结晶等后处理纯化后得到莱苞迪甙A 290.25g,纯度>95%。In the boric acid buffer solution, 300 g of stevioside, 150 g of sucrose and 2 g of UDP were added, respectively, and stirred until completely dissolved; 100 g of glucosyltransferase RA07 enzyme powder and 80 g of sucrose synthase (derived from Arabidopsis thaliana, NP_197583) were continuously added. The total volume of the reaction system was 1 L, and the pH of the system was adjusted to 7.4. The reaction was carried out for 20 h at a constant temperature of 37 ° C and a stirring rate of 300 rpm. The conversion was 96% by the experiment. After the reaction was completed, the reaction solution was heated to 100 ° C for 0.5 h. The protein of RA07 was denatured and filtered to remove the protein. The filtrate was collected and spray-dried to obtain a crude product of rebaudioside A. The crude product of rebaudioside A was separated by silica gel resin, crystallized, etc., and then purified to obtain a lycopene A 290.25g. , purity >95%.
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对本发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。The above-mentioned embodiments are merely illustrative of several embodiments of the present invention, and the description thereof is more specific and detailed, but is not to be construed as limiting the scope of the invention. It should be noted that a number of variations and modifications may be made by those skilled in the art without departing from the spirit and scope of the invention. Therefore, the scope of the invention should be determined by the appended claims.

Claims (10)

  1. 一种莱苞迪甙A的制备方法,其中,包括:A method for preparing Lai Di Di A, which comprises:
    在二磷酸尿苷葡萄糖和葡萄糖基转移酶存在下,以甜菊糖原料为底物配制反应液,调节所述反应液的pH为6.0-8.0,在恒定温度20-45℃下进行搅拌反应后,收集得到莱苞迪甙A;所述甜菊糖原料包括甜菊苷,所述葡萄糖基转移酶的氨基酸序列包括如SEQ ID NO:1所示的氨基酸序列。In the presence of uridine diphosphate glucose and glucosyltransferase, the reaction solution is prepared by using the stevioside raw material as a substrate, and the pH of the reaction solution is adjusted to 6.0-8.0, and after stirring at a constant temperature of 20-45 ° C, The rebaudioside A is collected; the stevioside material comprises stevioside, and the amino acid sequence of the glucosyltransferase comprises the amino acid sequence set forth in SEQ ID NO: 1.
  2. 如权利要求1所述的制备方法,其中,所述葡萄糖基转移酶的基因编码序列包括如SEQ ID NO:2所示的核苷酸序列。The production method according to claim 1, wherein the gene coding sequence of the glucosyltransferase comprises the nucleotide sequence shown as SEQ ID NO: 2.
  3. 如权利要求1所述的制备方法,其中,所述反应液中的所述二磷酸尿苷葡萄糖通过在所述反应液中直接加入或通过在所述反应液中加入混合原料获得,所述混合原料包括尿苷二磷酸和所述二磷酸尿苷葡萄糖中的一种或两种、蔗糖和蔗糖合成酶。The production method according to claim 1, wherein the uridine diphosphate glucose in the reaction liquid is obtained by directly adding in the reaction liquid or by adding a mixed raw material to the reaction liquid, the mixing. The raw material includes one or two of uridine diphosphate and the uridine diphosphate glucose, sucrose and sucrose synthase.
  4. 如权利要求3所述的制备方法,其中,当所述混合原料包括尿苷二磷酸、蔗糖和蔗糖合成酶时,所述尿苷二磷酸、所述蔗糖和所述蔗糖合成酶的质量比为(0.0001-0.04):(0.1-2):(0.1-1)。The production method according to claim 3, wherein when the mixed raw material comprises uridine diphosphate, sucrose, and sucrose synthase, the mass ratio of the uridine diphosphate, the sucrose, and the sucrose synthase is (0.0001-0.04): (0.1-2): (0.1-1).
  5. 如权利要求1所述的制备方法,其中,所述搅拌反应的反应时间为4-25小时。The production method according to claim 1, wherein the reaction time of the stirring reaction is 4 to 25 hours.
  6. 如权利要求1所述的制备方法,其中,所述甜菊糖原料在所述反应液中的质量分数为10%-30%。The production method according to claim 1, wherein the stevioside raw material has a mass fraction of 10% to 30% in the reaction liquid.
  7. 如权利要求1所述的制备方法,其中,所述甜菊糖原料与所述葡萄糖基转移酶的质量比为1:(0.1-1);所述葡萄糖基转移酶的添加形式包括粗酶液或酶粉。The preparation method according to claim 1, wherein a mass ratio of the stevioside raw material to the glucosyltransferase is 1: (1 - 1); and the added form of the glucosyltransferase includes a crude enzyme solution or Enzyme powder.
  8. 如权利要求1所述的制备方法,其中,所述收集得到莱苞迪甙A的过程包括:对所述反应液加热以使所述葡萄糖基转移酶变性,过滤并收集滤液,将所述滤液纯化处理后得到莱苞迪甙A,其中,所述加热的温度为85-100℃,时间为0.3-1小时。The production method according to claim 1, wherein the collecting the rebaudioside A comprises heating the reaction solution to denature the glucosyltransferase, filtering and collecting the filtrate, and the filtrate After the purification treatment, rebaudioside A is obtained, wherein the heating temperature is 85-100 ° C and the time is 0.3-1 hour.
  9. 一种莱苞迪甙A制备用酶,其中,所述制备用酶为葡萄糖基转移酶,所述葡萄糖基转移酶的基因编码序列包括如SEQ ID NO:2所示的核苷酸序列;所述葡萄糖基转移酶来源于栀子花。An enzyme for preparing a rebaudioside A preparation, wherein the preparation enzyme is a glucosyltransferase, and the gene coding sequence of the glucosyltransferase comprises a nucleotide sequence as shown in SEQ ID NO: 2; The glucosyltransferase is derived from gardenia.
  10. 葡萄糖基转移酶以及含有所述葡萄糖基转移酶的基因的微生物菌株在生物催化中的应用,其中,所述葡萄糖基转移酶的氨基酸序列包括如SEQ ID NO:1所示的氨基酸序列;所述葡萄糖基转移酶催化甜菊苷转化成莱苞迪甙A。Use of a glucosyltransferase and a microorganism strain containing the gene of the glucosyltransferase in biocatalysis, wherein the amino acid sequence of the glucosyltransferase comprises the amino acid sequence set forth in SEQ ID NO: 1; Glucosyltransferase catalyzes the conversion of stevioside to rebaudioside A.
PCT/CN2018/096211 2018-07-19 2018-07-19 Preparation method for rebaudioside a, enzyme for rebaudioside a preparation, and application WO2019161634A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN2018/096211 WO2019161634A1 (en) 2018-07-19 2018-07-19 Preparation method for rebaudioside a, enzyme for rebaudioside a preparation, and application
CN201880001964.4A CN109196110A (en) 2018-07-19 2018-07-19 Preparation method, rebandioside A alternation enzyme and the application of rebandioside A

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/096211 WO2019161634A1 (en) 2018-07-19 2018-07-19 Preparation method for rebaudioside a, enzyme for rebaudioside a preparation, and application

Publications (1)

Publication Number Publication Date
WO2019161634A1 true WO2019161634A1 (en) 2019-08-29

Family

ID=64938228

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/096211 WO2019161634A1 (en) 2018-07-19 2018-07-19 Preparation method for rebaudioside a, enzyme for rebaudioside a preparation, and application

Country Status (2)

Country Link
CN (1) CN109196110A (en)
WO (1) WO2019161634A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023030065A1 (en) * 2021-08-30 2023-03-09 弈柯莱生物科技(上海)股份有限公司 Glycosyltransferase and application thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113862319A (en) * 2021-09-16 2021-12-31 华南理工大学 Application of ginseng glycosyltransferase in synthesis of stevioside

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150000258A (en) * 2013-06-24 2015-01-02 한국생명공학연구원 Method for Preparing Natural High Intensity Sweetener Rebaudiside A by Using Enzymatic Conversion
CN105164270A (en) * 2013-02-28 2015-12-16 Cj第一制糖株式会社 Method for preparing rebaudioside A from stevioside

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105164270A (en) * 2013-02-28 2015-12-16 Cj第一制糖株式会社 Method for preparing rebaudioside A from stevioside
KR20150000258A (en) * 2013-06-24 2015-01-02 한국생명공학연구원 Method for Preparing Natural High Intensity Sweetener Rebaudiside A by Using Enzymatic Conversion

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE Protein 3 September 2014 (2014-09-03), NAGATOSHI M. ET AL.: "RecName: Full=7-deoxyloganetin glucosyltransferase; AltName: Full=Genipin glucosyltransferase; AltName: Full=UDP-glucose glucosyltransferase 2; Short=GjUGT2; AltName: Full=UDP-glycosyltransferase 85A24", XP055633210, retrieved from NCBI Database accession no. F8WKW1.1 *
DU TING ET AL.: "Synthesis, recombinant expression of arabidopsis sucrose synthase gene and its preliminary application in enzymatic synthesis of rebaudioside s", SCIENCE AND TECHNOLOGY OF FOOD INDUSTRY, vol. 36, no. 23, 1 December 2015 (2015-12-01), pages 157 - 161 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023030065A1 (en) * 2021-08-30 2023-03-09 弈柯莱生物科技(上海)股份有限公司 Glycosyltransferase and application thereof

Also Published As

Publication number Publication date
CN109196110A (en) 2019-01-11

Similar Documents

Publication Publication Date Title
US11203742B2 (en) Sucrose phosphorylase mutant with improved enzyme activity and construction method thereof and use thereof
US20210254031A1 (en) Engineered strain for producing allulose and derivatives thereof, method for construction therefor and use thereof
TWI682998B (en) A composition for producing tagatose and methods for producing tagatose using the same
EP4365285A1 (en) Glycosyltransferase mutant and method for catalytic synthesis of rebaudioside m by means of using same
CN111647579B (en) Thermolabile exoinulase mutant MutQ23 delta 9 and preparation and application thereof
CN111471637A (en) 2' -fucosyllactose high-yield strain and preparation method and application thereof
US11352653B2 (en) Enzymatic method for preparing rebaudioside N
KR102076288B1 (en) A composition for preparing tagatose and Methods for producing tagatose using The Same
CN107446874B (en) Recombinant escherichia coli and application thereof in synthesizing rebaudioside D
CN113774036A (en) Imine reductase mutant and application thereof
WO2019161634A1 (en) Preparation method for rebaudioside a, enzyme for rebaudioside a preparation, and application
WO2024152535A1 (en) Imine reductase mutant, and use thereof and use method therefor
TWI819660B (en) Novel uridine diphosphate glycosyltransferase and use thereof
US20160138005A1 (en) Expression system for psicose epimerase and production for psicose using the same
WO2019100676A1 (en) Preparation method for enzyme-modified stevioside, enzyme for said preparation method, and application thereof
CN113005132B (en) D-psicose-3-epimerase gene and application method thereof
WO2024045796A1 (en) Cyclodextrin glucosyltransferase with improved solvent tolerance and preparation thereof
KR20020051835A (en) Thermostable L-Arabinose Isomerase and Process for Preparing D-tagatose thereby
KR100387302B1 (en) Recombinant enzyme converts maltose to trehalose
CN109234340B (en) Method for catalytically synthesizing rebaudioside M by recombinant yeast
JP2019532650A (en) Method for preparing rebaudioside C by using an enzymatic method
CN111548978B (en) Bacillus subtilis for producing mannan and application thereof
CN116064494B (en) Glutamate decarboxylase mutant, gene and application thereof
CN116254279B (en) Method for catalyzing xylitol to biosynthesize L-xylose by using double-enzyme cascade recombinant escherichia coli
CN111607548B (en) Recombinant escherichia coli for producing mannan and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18906760

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM1205A DATED 10.06.2021)

122 Ep: pct application non-entry in european phase

Ref document number: 18906760

Country of ref document: EP

Kind code of ref document: A1